CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CANbridge Pharmaceuticals Inc. has announced its board composition, including Executive Director Dr. James Qun Xue as Chairman and CEO, alongside a list of Non-executive and Independent Non-executive Directors. The company’s board includes three key committees: Audit, Remuneration, and Nomination and Corporate Governance, with various members serving as chairpersons and committee members.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.